from [dDT] GILD. FDA play this week (chart): http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75256722 calendar. 5/10/2012 GILD Gilead Sciences Inc. Truvada (sNDA) FDA panel to review Truvada in new indication as HIV preventive therapy 5/11/2012 GILD Gilead Sciences Inc. Quad (NDA) FDA panel to review Quad in potential treatmentof HIV Recent PR's. http://ih.advfn.com/p.php?pid=squote&symbol=gild